Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Oon

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Rheumatology International|July 31, 2024
Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional surveyBenjamin Sutu, Samuel Maxwell, Shereen Oon, et al.
Journal of Medical Imaging and Radiation Oncology|October 7, 2015
Gouty arthropathy: Review of clinico-pathologic and imaging featuresNishanthinie Parathithasan, Wai-Kit Lee, Marcus Pianta, et al.
Seminars in Arthritis and Rheumatism|July 26, 2024
Muscle biopsy practices in the evaluation of idiopathic inflammatory myopathies: An international survey of expert cliniciansSamuel Maxwell, Laura Ross, Shereen Oon, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Imaging findings of scleroderma-associated myopathy: A systematic literature reviewElvina Ingrid, Mathuja Bavanendrakumar, Shereen Oon, et al.
Seminars in Arthritis and Rheumatism|July 2, 2024
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature reviewSasza Koczanowski, Kathleen Morrisroe, Jessica Fairley, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosusShereen Oon, Molla Huq, Vera Golder, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
RMD Open|April 24, 2025
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteriaIoannis Parodis, Julius Lindblom, Leonardo Palazzo, et al.
Clinical Rheumatology|October 1, 2021
Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohortYanjie Hao, Shereen Oon, Lanlan Ji, et al.
Clinical & Translational Immunology|January 1, 2020
A potential association between IL-3 and type I and III interferons in systemic lupus erythematosusShereen Oon, Katherine Monaghan, Milica Ng, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Rheumatology International|July 31, 2024
Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional surveyBenjamin Sutu, Samuel Maxwell, Shereen Oon, et al.
Journal of Medical Imaging and Radiation Oncology|October 7, 2015
Gouty arthropathy: Review of clinico-pathologic and imaging featuresNishanthinie Parathithasan, Wai-Kit Lee, Marcus Pianta, et al.
Seminars in Arthritis and Rheumatism|July 26, 2024
Muscle biopsy practices in the evaluation of idiopathic inflammatory myopathies: An international survey of expert cliniciansSamuel Maxwell, Laura Ross, Shereen Oon, et al.
Seminars in Arthritis and Rheumatism|March 4, 2025
Imaging findings of scleroderma-associated myopathy: A systematic literature reviewElvina Ingrid, Mathuja Bavanendrakumar, Shereen Oon, et al.
Seminars in Arthritis and Rheumatism|July 2, 2024
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature reviewSasza Koczanowski, Kathleen Morrisroe, Jessica Fairley, et al.
Annals of the Rheumatic Diseases|January 26, 2019
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosusShereen Oon, Molla Huq, Vera Golder, et al.
Annals of the Rheumatic Diseases|April 4, 2020
Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLECynthia Aranow, Anca Askanase, Shereen Oon, et al.
RMD Open|April 24, 2025
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteriaIoannis Parodis, Julius Lindblom, Leonardo Palazzo, et al.
Clinical Rheumatology|October 1, 2021
Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohortYanjie Hao, Shereen Oon, Lanlan Ji, et al.
Clinical & Translational Immunology|January 1, 2020
A potential association between IL-3 and type I and III interferons in systemic lupus erythematosusShereen Oon, Katherine Monaghan, Milica Ng, et al.
Pageof 6